Company Information
Company name：Tamakona,Inc.
Established in：Oct 1, 2019
Head Office：
6-5-5 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JAPAN
Contact：Please contact us onInqury Form
History
Food allergies have been on the rise in recent years, and egg is one of the most common food allergens for infants. Oral food challenges (OFCs) for eggs are now being conducted by administering boiled eggs or other egg products at clinics and hospitals. However, there is a need for standardized and consistent food for OFC to improve its quality and reliability. We also believe that it would be beneficial to make it easier to conduct not only OFC, but also quantitative intake at home and oral immunotherapy as clinical research. To address this need, the “Development of cooked hen’s egg powder for food allergy” project was launched. This project was accelerated by obtaining a competitive research grant from the Foundation for Biomedical Research and Innovation at Kobe, which president is Dr. Tasuku Honjo, a Novel Prize-winning scientist, in 2018. The project was based on continuous research by Professor Motohiro Ebisawa, a former president of the World Allergy Organization, since the 2000s, and was supported by a grant from the Japanese Ministry of Health, Labour and Welfare （Health Labour Sciences Research Grant）as a primary investigator. Professor Ebisawa has been committed to standardizing OFC in clinical practice to improve the quality and safety of OFC. We, Tamakona, are continuing this project under his supervision and collaborating with doctors and nutritionists specializing in food allergy research throughout Japan to further improve our product. Our cooked egg powder product, named “Tamakona”, represents the culmination of extensive research and a deep commitment to improving clinical practice for food allergies.
- 2000s
-
Professor Ebisawa obtained a Health Labour Sciences Research Grant, and launched a research project, that served as the basis for Tamakona, developing protocols and challenge meals toward standardizing OFC.
- Jun. 2018
-
A consortium was formed with Kobe City Medical Center General Hospital, Hyogo prefectural Kobe Children’s Hospital, Takatsuki General Hospital, Chibune General Hospital, Beppu University.
- Aug. 2018
-
The consortium obtained a competitive research grant from the Foundation for Biomedical Research and Innovation at Kobe.
- Oct. 2019
-
Tamakona, Inc. was established.
- Nov. 2019
-
The sales of “Tamakona 250″ started.
Tamakona, Inc. participated in a company exhibition at the 56th Annual Meeting of the Japanese Society of Pediatric Allergy.
- Mar. 2021
-
Our products “Tamakona 250” and “Tamakona 750” were featured as foods for oral food challenge tests in the Guide of Oral Food Challenge 2020 in Japan, supported by Health Labor Sciences Research Grant.
- Nov. 2021
-
Tamakona was introduced as a food powder for OFC in the Food Allergy Treatment Guidelines 2021, published by the Japanese Society of Pediatric Allergy.
- Apr. 2022
-
The sales of “Milkona 100” started.
- Oct. 2022
-
The sales of “Tamakona 750″ started.
- Nov. 2022
-
The sales of “Tamakona 25″ started.
Tamakona,Inc. participated in a company exhibition at the 59th Annual Meeting of the Japanese Society of Pediatric Allergy. - Nov. 2023
-
Tamakona,Inc. participated in a company exhibition at the 60th Annual Meeting of the Japanese Society of Pediatric Allergy.
- Mar. 2024
-
“Tamakona” and “Milkona” were featured as specific foods for oral food challenge tests in the Guide of Oral Food Challenge 2023 in Japan, supported by Health Labor Sciences Research Grant.
- May. 2024
-
Tamakona,Inc. participated in a company exhibition at the European Academy of Allergy and Clinical Immunology Congress (EAACI) 2024 in Valencia, Spain.
- Jun. 2024
-
Our exhibition in EAACI2024 was selected for the FY2024 Overseas Expansion Support Subsidy by the Hyogo Overseas Business Center.
- Jul. 2024
-
Tamakona,Inc. participated in a company exhibition at the 40th Annual Meeting of the Japanese Society of Pediatric Clinical Allergy.
- Nov. 2024
-
Tamakona,Inc. participated in a company exhibition at the 61st Annual Meeting of the Japanese Society of Pediatric Allergy.
- May. 2025
-
Tamakona,Inc. partnered with BeeCruise Inc. to support personal imports for overseas customers in some countries.
- Jun. 2025
-
Tamakona,Inc. participated in a company exhibition at the European Academy of Allergy and Clinical Immunology Congress (EAACI) 2025 in Glasgow, Scotland.